A second-derivative scan of an acidified urine sample allows the amplitude of deflection (LA) and the minimum wavelength of the trough (Amin) to determine the correct porphyrin concentration and the coproporphyrin:uroporphyrin (copro:uro) ratio, respectively, from a nomogram constructed from calibrator solutions. We measured 24 urine samples for total porphyrinas coproporphyrinequivalents and adjusted the results with factors from the no- Results of the copro:uro ratio derived by second-derivative spectroscopy and HPLC showed no significantdifference (i-test) from samples with various copro:uro ratios. Recovery studies on four urine samples supplemented with known proportions of coproporphyrins and uroporphyrins gave good agreement between the measured and the expected porphyrin ratios. The overall imprecision (CV) of the assay ranged from 3.6% to 6.0% for coproporphyrin and from 3.2% to 9.1% for uroporphyrin.
Materials and Methods
A single-beam spectrophotometer, Model DU-70 (Beckman Instruments, Fullerton, CA), capable of generating a second-derivative scan was used in this study. We used urine samples from porphyric patients, normal random urines supplemented with coproporphyrins and uroporphyrins, and quality-control 
Procedure.
The procedure proposed by Jones and Sweeney is determined from the trough (Fig. 1) .
Nomogram derivation. (Fig. 2) . We compared the copro:uro ratios of porphyrin-supplemented samples, porphyric patients' samples, and QC samples with those obtained by
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HPLC (5).
A recovery study was carried out on urine samples supplemented with known proportions of coproporphyrims and uroporphyrins.
For the precision study, two urine samples were assayed in triplicate over 3 days.
Statistical analysis was done with the Statgraphics version 5 software package (STSC, Rockville, MD).
Results
The total porphyrin concentrations of 24 urine samples measured as coproporphyrin equivalents are shown in Table 1 The adjusted results (mean ± SE, 501 ± 57 nmol/L) compared favorably with the expected results (514 ± 57 nmoIJL). Likewise, the adjusted results for the uroporphyrin-rich urine samples compared favorably with the expected results. rin-supplemented samples, both methods identified five increased copro:uro ratios, nine increased uro:copro ratios, and two similar copro:uro ratios. Five of seven urine samples from porphyric patients had increased copro:uro ratios, whereas the remaining two had in- Biochemists) by the second-derivative and HPLC methods. With another 10 QAP samples, the average copro:uro ratio by the second-derivative method was 33:67 vs the overall mean (consensus value) of 32:68, and there was good agreement between both methods for each sample.
Results from the recovery study are shown in Table 3 of the porphyrin as coproporphyrin equivalents (4), with adjustment to the correct value with the appropriate correction factor. For this last approach, a correction factor curve (Fig. 2) has been constructed by relating the iA values of uroporphyrin and the copro:uro mixtures to unity, the iA of coproporphy- 
